Cytokine | Item | β (95% CI) | Wald χ2 | P value |
---|---|---|---|---|
IL-2 | Time | Â | Â | Â |
 | Baseline | 0a |  |  |
 | Week 2 | −0.079(−0.141,-0.017) | 6.190 | 0.013 |
 | Week 4 | −0.044(−0.145,0.058) | 0.711 | 0.399 |
 | Outcome |  |  |  |
 | Survival | 0a |  |  |
 | Death | 0.030(−0.044,0.104) | 0.622 | 0.430 |
IL-13 | Time | Â | Â | Â |
 | Baseline | 0a |  |  |
 | Week 2 | −1.039(−1.910,-0.168) | 5.466 | 0.019 |
 | Week 4 | 2.137(−3.364,7.638) | 0.580 | 0.446 |
 | Outcome |  |  |  |
 | Survival | 0a |  |  |
 | Death | −1.475(−3.066,0.116) | 3.304 | 0.069 |
IL-17A | Time | Â | Â | Â |
 | Baseline | 0a |  |  |
 | Week 2 | −0.209(−0.360,-0.058) | 7.327 | 0.007 |
 | Week 4 | −0.145(−0.311,0.021) | 2.929 | 0.087 |
 | Outcome |  |  |  |
 | Survival | 0a |  |  |
 | Death | 0.239(−0.038,0.516) | 2.849 | 0.091 |
VEGF-A | Time | Â | Â | Â |
 | Baseline | 0a |  |  |
 | Week 2 | −0.053(−0.101,-0.005) | 4.619 | 0.032 |
 | Week 4 | −0.103(− 0.196,-0.010) | 4.713 | 0.030 |
 | Outcome |  |  |  |
 | Survival | 0a |  |  |
 | Death | −0.130(−0.293,0.033) | 2.456 | 0.117 |